173 related articles for article (PubMed ID: 11687148)
1. Systemic therapy for treating locoregional recurrence in women with breast cancer.
Rauschecker H; Clarke M; Gatzemeier W; Recht A
Cochrane Database Syst Rev; 2001; 2001(4):CD002195. PubMed ID: 11687148
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet; 2023 Nov; 402(10416):1991-2003. PubMed ID: 37931633
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC).
Sarcoma Meta‐analysis Collaboration (SMAC) ‐ see acknowledgement section for list of authors
Cochrane Database Syst Rev; 2000; 2000(2):CD001419. PubMed ID: 10796873
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for women over age 65 with breast cancer.
Sautter-Bihl ML; Souchon R; Gerber B
Dtsch Arztebl Int; 2011 May; 108(21):365-71. PubMed ID: 21691560
[TBL] [Abstract][Full Text] [Related]
5. Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes.
Belkacemi Y; Hanna NE; Besnard C; Majdoul S; Gligorov J
Front Oncol; 2018; 8():112. PubMed ID: 29719816
[TBL] [Abstract][Full Text] [Related]
6. Options for early breast cancer follow-up in primary and secondary care - a systematic review.
Taggart F; Donnelly P; Dunn J
BMC Cancer; 2012 Jun; 12():238. PubMed ID: 22695275
[TBL] [Abstract][Full Text] [Related]
7. Impact of Radiation Therapy Modalities on Loco-regional Control in Inflammatory Breast Cancer.
Rogé M; Kirova Y; Lévêque E; Guigo M; Johnson A; Nebbache R; Rivin Del Campo E; Lazarescu I; Servagi S; Mervoyer A; Cailleteau A; Thureau S; Thariat J
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38621608
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents.
Untch M; von Minckwitz G
Breast Cancer Res; 2009; 11(2):203. PubMed ID: 19344488
[TBL] [Abstract][Full Text] [Related]
9. Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer.
Thomsen AR; Sahlmann J; Bronsert P; Schilling O; Poensgen F; May AM; Timme-Bronsert S; Grosu AL; Vaupel P; Gebbers JO; Multhoff G; Lüchtenborg AM
Front Oncol; 2023; 13():1275222. PubMed ID: 38169879
[TBL] [Abstract][Full Text] [Related]
10. Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.
Gerber B; Freund M; Reimer T
Dtsch Arztebl Int; 2010 Feb; 107(6):85-91. PubMed ID: 20204119
[TBL] [Abstract][Full Text] [Related]
11. [Not Available].
Bjerre CA; Rønlev JD; Knop AS
Ugeskr Laeger; 2024 Mar; 186(12):. PubMed ID: 38533871
[TBL] [Abstract][Full Text] [Related]
12. SEOM clinical guidelines in advanced and recurrent breast cancer (2018).
Chacón López-Muñiz JI; de la Cruz Merino L; Gavilá Gregori J; Martínez Dueñas E; Oliveira M; Seguí Palmer MA; Álvarez López I; Antolin Novoa S; Bellet Ezquerra M; López-Tarruella Cobo S
Clin Transl Oncol; 2019 Jan; 21(1):31-45. PubMed ID: 30617924
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the combination of radiotherapy and immunotherapy for breast cancer.
Zhang R; Clark SD; Guo B; Zhang T; Jeansonne D; Jeyaseelan SJ; Francis J; Huang W
Expert Rev Anticancer Ther; 2023 Apr; 23(4):375-383. PubMed ID: 37039098
[TBL] [Abstract][Full Text] [Related]
14. [Staging and systemic treatment of ocular and periocular metastases].
Dörfel D; Babst N; Heindl LM; Kakkassery V; Müller MR
Ophthalmologie; 2024 May; 121(5):374-381. PubMed ID: 38683363
[TBL] [Abstract][Full Text] [Related]
15. Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know.
Teven CM; Schmid DB; Sisco M; Ward J; Howard MA
Eplasty; 2017; 17():e7. PubMed ID: 28293332
[No Abstract] [Full Text] [Related]
16. The Relationship Between Periodontal Disease and Breast Cancer: From Basic Mechanism to Clinical Management and Prevention.
Zhang Y; Ren X; Hu T; Cheng R; Bhowmick NA
Oral Health Prev Dent; 2023 Feb; 21():49-60. PubMed ID: 36794777
[TBL] [Abstract][Full Text] [Related]
17. Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.
Azria D; Brengues M; Gourgou S; Bourgier C
Front Oncol; 2018; 8():83. PubMed ID: 29675397
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.
Aebi S; Gelber S; Anderson SJ; Láng I; Robidoux A; Martín M; Nortier JW; Paterson AH; Rimawi MF; Cañada JM; Thürlimann B; Murray E; Mamounas EP; Geyer CE; Price KN; Coates AS; Gelber RD; Rastogi P; Wolmark N; Wapnir IL;
Lancet Oncol; 2014 Feb; 15(2):156-63. PubMed ID: 24439313
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
Wapnir IL; Price KN; Anderson SJ; Robidoux A; Martín M; Nortier JWR; Paterson AHG; Rimawi MF; Láng I; Baena-Cañada JM; Thürlimann B; Mamounas EP; Geyer CE; Gelber S; Coates AS; Gelber RD; Rastogi P; Regan MM; Wolmark N; Aebi S; ; ;
J Clin Oncol; 2018 Apr; 36(11):1073-1079. PubMed ID: 29443653
[TBL] [Abstract][Full Text] [Related]
20. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
